A carregar...
Defining key signaling nodes and therapeutic biomarkers in NF1-mutant cancers
NF1 encodes a RAS GTPase-Activating Protein. Accordingly, aberrant RAS activation underlies the pathogenesis of NF1-mutant cancers. Nevertheless, it is unclear which RAS pathway components represent optimal therapeutic targets. Here we identify mTORC1 as the key PI3K effector in NF1-mutant nervous s...
Na minha lista:
| Publicado no: | Cancer Discov |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4446704/ https://ncbi.nlm.nih.gov/pubmed/24913553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-14-0159 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|